Zobrazeno 1 - 10
of 10
pro vyhledávání: '"K A Denholm"'
Publikováno v:
British Journal of Surgery. 108
Aim Silent sinus syndrome is a rare condition characterised by progressive, painless enophthalmos with subsequent development of hypoglobus due to orbital floor resorption. It is caused by hypoplasia of the ipsilateral maxillary sinus due to atelecta
Publikováno v:
The British journal of oralmaxillofacial surgery. 59(5)
Publikováno v:
Proceedings of Soil Specific Crop Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f468517e7772386af75d54c32ec14c8b
https://doi.org/10.2134/1993.soilspecificcrop.c33
https://doi.org/10.2134/1993.soilspecificcrop.c33
Autor:
Kirsty Moran, Amy Mulick Cassidy, Stanley B. Kaye, Timothy A. Yap, Jen Kate Lewis, Ruth Riisnaes, Géraldine Perkins, Jesus Corral Jaime, Sadiya Saeed, Michael Ong, Helen Nicole Toloui, L Rhoda Molife, Khin Thway, Lorna Pope, Udai Banerji, Joaquin Mateo, K. A. Denholm, Andrea Biondo, Penelope Flohr, Johann S. de Bono
Publikováno v:
Journal of Clinical Oncology. 30:10525-10525
10525 Background: Studies suggest that tumoral cfDNA can be isolated from plasma and used as a biomarker. Methods: We conducted a prospective study in adult pts with advanced cancer referred for phase I clinical trials Sep09-Dec10 (A: Pilot Phase n=1
Autor:
Martina Uttenreuther-Fischer, Susanne Buschke, David Propper, L. R. Molife, James Spicer, D. O'Brien, L. Trani, E. Bent, H. Kristeleit, K. A. Denholm, M. Puglisi, Muireann Kelleher, Gary Middleton, Gudrun Wallenstein, Peter Stopfer
Publikováno v:
Journal of Clinical Oncology. 29:2613-2613
2613^ Background: Afatinib (BIBW 2992) is an oral, irreversible ErbB family blocker. This trial prospectively evaluated the possible proarrhythmic potential of afatinib by assessing QTc interval, as well as its PK and clinical efficacy. Methods: Pati
Autor:
N. Tunariu, David Mansfield, T. A. Yap, M. Puglisi, Kevin J. Harrington, K. A. Denholm, J.S. de Bono, J. V. Pedersen, Eleni M. Karapanagiotou, A. Biondo, Salem Sassi
Publikováno v:
Journal of Clinical Oncology. 29:2577-2577
2577 Background: GL-ONC1 is a genetically engineered vaccinia virus attenuated by insertion of the ruc-gfp (Renilla luciferase and Aequorea green fluorescent protein fusion gene), beta-galactosidase (lacZ) and beta-glucuronidase (gusA) reporter genes
Autor:
Timothy A. Yap, Stan B. Kaye, Géraldine Perkins, Lorna Pope, Juliet P. Dukes, Ruth Riisnaes, Jeremy Clark, K. A. Denholm, Johann S. de Bono, Amy Mulick Cassidy
Publikováno v:
Cancer Research. 71:3072-3072
Background: Circulating free DNA (cfDNA) represents a minimally-invasive resource for detecting mutations in advanced cancer patients. The primary objective of this study was to determine if cfDNA is representative of tumor tissue for multiplex mutat
Autor:
Géraldine Perkins, Lorna Pope, Aaron Cassidy, D. Gonzalez de Castro, K. A. Denholm, J.S. de Bono, Ian Chau, T. A. Yap, Ruth Riisnaes, Juliet P. Dukes
Publikováno v:
Journal of Clinical Oncology. 29:356-356
356 Background: Circulating free DNA (cfDNA) represents a minimally-invasive resource for detecting mutations in advanced cancer patients. The primary objective of this study was to determine if cfDNA is representative of tumor tissue for multiplex m
Autor:
S. B. Kaye, D. S. Tan, B. Ayite, David Olmos, Sophia Frentzas, T. A. Yap, K. A. Denholm, Shahneen Sandhu, J.S. de Bono, Andre T. Brunetto
Publikováno v:
European Journal of Cancer Supplements. 7:138
Autor:
K. D. Denholm
Publikováno v:
The Geographical Journal. 157:120